Labetuzumab
Labetuzumab ( marketed under the trade name CEA-CIDE ) is a humanized IgG1 monoclonal antibody for the treatment of colorectal cancer . 
<triplet> Labetuzumab <subj> monoclonal antibody <obj> instance of <triplet> humanized <subj> monoclonal antibody <obj> subclass of